Literature DB >> 2822906

Central and peripheral cocaine receptors.

D O Calligaro1, M E Eldefrawi.   

Abstract

High-affinity binding sites for [3H]cocaine (levo-[benzoyl-3,4-3H(N)]) were detected in membrane preparations from rat brain and liver. Analysis of binding to rat whole brain membranes revealed a high-affinity site (Kd = 16 nM) present at 0.65 pmol/mg of protein and a lower affinity site of (Kd = 660 nM) present at 5.1 pmol/mg of protein. The striatum had a much higher density of [3H]cocaine binding sites than either the frontal or occipital cortices. Also, the ratio of high/low affinity sites was highest for striatum, lower for cortices and lowest for whole brain. Scatchard analysis of cocaine binding to striatum and cortex suggested that, in addition to the high affinity binding (Kd = 16 nM), there were two or more lower affinity sites. Liver membranes bound [3H]cocaine with a single high affinity (Kd = 1.7 nM) present at high concentrations (Bmax = 66 pmol/mg of protein). Binding of cocaine to both brain and liver membranes was sensitive to proteases, reduced by high Na+ concentrations (30-100 mM), eliminated by denaturing temperatures (i.e., 95 degrees C for 5 min) and optimal at pH 7.4. Binding of [3H]cocaine to the striatal and cortical synaptic membranes was inhibited by cocaine and analogs in the following decreasing rank order: (-)-cocaine greater than (-)-norcocaine greater than (-)-cinnamoylcocaine greater than (+)-pseudococaine but (-)-ecgonine had no effect. The effective analogs also inhibited [3H]norepinephrine (levo[7-3H(N)]) and [3H]dopamine (dihydroxyphenylethylamine, 3,4-[7-3H]) uptake into cortical and striatal synaptosomes, respectively, with similar rank order.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2822906

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

1.  Temporal relationships between the pharmacokinetics of methylphenidate in the human brain and its behavioral and cardiovascular effects.

Authors:  N D Volkow; G J Wang; S J Gatley; J S Fowler; Y S Ding; J Logan; R Hitzemann; B Angrist; J Lieberman
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

2.  Effects of acute and subacute cocaine administration on the CNS dopaminergic system in Wistar-Kyoto and spontaneously hypertensive rats: I. Levels of dopamine and metabolites.

Authors:  Z J Yu; D K Lim; B Hoskins; R W Rockhold; I K Ho
Journal:  Neurochem Res       Date:  1990-06       Impact factor: 3.996

3.  Cocaine binding sites in fetal rat brain: implications for prenatal cocaine action.

Authors:  J S Meyer; L P Shearman; L M Collins; R L Maguire
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  Studies of the biogenic amine transporters. 1. Dopamine reuptake blockers inhibit [3H]mazindol binding to the dopamine transporter by a competitive mechanism: preliminary evidence for different binding domains.

Authors:  C M Dersch; H C Akunne; J S Partilla; G U Char; B R de Costa; K C Rice; F I Carroll; R B Rothman
Journal:  Neurochem Res       Date:  1994-02       Impact factor: 3.996

5.  Effects of cocaine on [11C]norepinephrine and [11C] beta-CIT uptake in the primate peripheral organs measured by PET.

Authors:  T Suhara; L Farde; C Halldin; K Någren; P Karlsson
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

6.  Cocaine acts as an apparent competitive inhibitor at the outward-facing conformation of the human norepinephrine transporter: kinetic analysis of inward and outward transport.

Authors:  N Chen; J B Justice
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

7.  Synthesis, radiosynthesis and in vivo evaluation of [I]-4-(2-(bis(4-fluorophenyl)methoxy)ethyl)-1-(4-iodobenzyl)piperidine as a selective tracer for imaging the dopamine transporter.

Authors:  S De Bruyne; T L Boos; L Wyffels; J L Goeman; K C Rice; F De Vos
Journal:  J Labelled Comp Radiopharm       Date:  2009-05-28       Impact factor: 1.921

8.  Interaction of two sulfhydryl reagents with a cation recognition site on the neuronal dopamine carrier evidences small differences between [3H]GBR 12783 and [3H]cocaine binding sites.

Authors:  F Refahi-Lyamani; S Saadouni; J Costentin; J J Bonnet
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-02       Impact factor: 3.000

9.  Fate of systemically administered cocaine in nonhuman primates treated with the dAd5GNE anticocaine vaccine.

Authors:  Martin J Hicks; Stephen M Kaminsky; Bishnu P De; Jonathan B Rosenberg; Suzette M Evans; Richard W Foltin; David M Andrenyak; David E Moody; George F Koob; Kim D Janda; Rodolfo J Ricart Arbona; Michelle L Lepherd; Ronald G Crystal
Journal:  Hum Gene Ther Clin Dev       Date:  2014-03       Impact factor: 5.032

10.  A high-affinity cocaine binding site associated with the brain acid soluble protein 1.

Authors:  Maged M Harraz; Adarsha P Malla; Evan R Semenza; Maria Shishikura; Manisha Singh; Yun Hwang; In Guk Kang; Young Jun Song; Adele M Snowman; Pedro Cortés; Senthilkumar S Karuppagounder; Ted M Dawson; Valina L Dawson; Solomon H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2022-04-11       Impact factor: 12.779

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.